apl. Prof. Dr. Udo Gaipl

Medizinische Fakultät Department of Radiation Oncology

12 x 6 Gy stereotactic radiotherapy for lung tumours. Is there a difference in response between lung metastases and primary bronchial carcinoma? (2021) Lubgan D, Semrau S, Lambrecht U, Gaipl U, Fietkau R Conference contribution Prospective Assessment of the Inflammation Parameters in Blood Counts and Blood Serum as prognostic/predictive Parameters for Treatment with Immune Checkpoint-Inhibitors (2021) Schweizer C, Haderlein M, Schubert P, Zhou J, Semrau S, Rutzner S, Gostian AO, et al. Conference contribution The IMMO-LDRT01 Study - Analgesic and immunomodulatory Effects of LDRT in Patients with chronic degenerative and inflammatory Diseases (2021) Donaubauer AJ, Fröhlich B, Becker I, Weissmann T, Fietkau R, Ott O, Gaipl U, Frey B Conference contribution Hypofractionated Radiation increases the Expression of the Immune Checkpoint-Molecule HVEM on TS/A Breast Cancer- and B16 Melanoma Cells (2021) Flohr AS, Grün A, Fietkau R, Rückert M, Gaipl U Conference contribution Detection of Human Cytomegalovirus (HCMV) in monocytic Cells of the peripheral Blood in Glioma Patients during Radio (chemo) Therapy (2021) Bäumler M, Becker I, Frey B, Pohn A, Winkler T, Fietkau R, Gaipl U Conference contribution Low-Dose Radiotherapy is highly effective in the Treatment of painful Finger Polyarthrosis (2021) Weissmann T, Gaipl U, Putz F, Hecht M, Donaubauer AJ, Zhou J, Fietkau R, et al. Conference contribution The Growth of primary and abscopal Tumors as well as their immunological Microenvironment are differently influenced by different Combinations of Radiation and Immunotherapies (2021) Rückert M, Deloch L, Frey B, Fietkau R, Gaipl U Conference contribution Progress Patterns under Radioimmunotherapy - clinical Evaluation of the prospective STICI Study (2021) Schubert P, Schweizer C, Roesch J, Haderlein M, Rutzner S, Semrau S, Donaubauer AJ, et al. Conference contribution In Vitro Examinations of Cell Death Induction and the Immune Phenotype of Cancer Cells Following Radiative-Based Hyperthermia with 915 MHz in Combination with Radiotherapy (2021) Hader M, Streit S, Rosin A, Gerdes T, Wadepohl M, Bekeschus S, Fietkau R, et al. Journal article Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration. (2021) Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution